CELONIC Group
  1. Companies
  2. CELONIC Group
  3. Services
  4. Formulation Development Services

Formulation Development Services

SHARE

ProJect Pharmaceutics* builds quality into formulation and processes and applies high-throughput predictive stability technologies (Predictive Formulation Analytics, PFA) to ensure manufacturing consistency. Using such a regulatory-compliant Quality by Design (QbD) step at an early stage will result in an accelerated and risk-mediated downstream process (DSP) development. It will also generate a more stable final drug substance formulation that, ideally, results in a consistent formulation for drug substances and products.

Most popular related searches
  • Quick identification of protein’s likes/dislikes (comfort zone) based on basic formulation profiling
  • Optimized yield based on rationale design of stabilization concepts per DSP step within identified comfort zones
  • Minimized aggregation tendency, even at high concentrations, based on rationale UF/DF development
  • Accelerated drug product formulation based on thorough DSP groundwork

*A sister company of Celonic